Artific 3

DRUG2 trials

Sponsors

Biotechnology Institue I Mas D S.L.

Conditions

Dry Eye Disease

Phase 4

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

WithdrawnCTIS2023-507357-15-00

Biotechnology Institue I Mas D S.L.Dry Eye Disease

Target: 54Updated: 2024-08-26

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

Not yet recruitingCTIS2023-507357-15-01

Biotechnology Institue I Mas D S.L.Dry Eye Disease

Target: 54Updated: 2025-07-23